# Ache Laboratorios Farmaceuticos S.A. trials: 36 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 36 trials with Ache Laboratorios Farmaceuticos S.A. as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ache Laboratorios Farmaceuticos S.A.: 36 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ache-laboratorios-farmaceuticos-s-a

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 36
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 36, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 19, 2026 | NCT07880392 | Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Not yet recruiting | Acute Pain | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880392) |
| June 1, 2026 | NCT07617532 | Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Not yet recruiting | Ocular Hypertension, Primary Open Angle Glaucoma | 336 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617532) |
| December 8, 2025 | NCT07270432 | Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Not yet recruiting | Prostatic Hyperplasia, Benign | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270432) |
| August 29, 2024 | NCT06577077 | Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Unknown | Rhinitis, Allergic, Perennial | 432 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06577077) |
| April 10, 2024 | NCT06355856 | Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss | Ache Laboratorios Farmaceuticos S.A. | Phase 4 | Unknown | Alopecia | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06355856) |
| July 27, 2020 | NCT04487860 | Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo | Ache Laboratorios Farmaceuticos S.A. | Phase 2 | Completed | Non-segmental Vitiligo | 327 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04487860) |
| August 16, 2018 | NCT03634514 | Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy... | Ache Laboratorios Farmaceuticos S.A. | Phase 4 | Unknown | Healthy Subjects | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03634514) |
| April 25, 2018 | NCT03508167 | Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band... | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Low Back Pain | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03508167) |
| December 7, 2016 | NCT02985671 | To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared... | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Unknown | Postural Low Back Pain, Mechanical Low Back Pain | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02985671) |
| October 31, 2016 | NCT02949089 | ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects | Ache Laboratorios Farmaceuticos S.A. | Phase 1 | Completed | Diarrhea | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02949089) |
| September 16, 2016 | NCT02904304 | Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Suspended | Cold | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02904304) |
| August 3, 2016 | NCT02853578 | Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Suspended | Asthma | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02853578) |
| June 14, 2016 | NCT02798367 | Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia | Ache Laboratorios Farmaceuticos S.A. | Phase 2/3 | Unknown | Insomnia Disorder | 307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02798367) |
| March 23, 2016 | NCT02716090 | Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Acne Vulgaris | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02716090) |
| March 18, 2016 | NCT02713139 | Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies. | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Sexual Active Women, Vaginal Discharge | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02713139) |
| March 11, 2016 | NCT02706015 | Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Migraine Headache | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02706015) |
| October 22, 2015 | NCT02584010 | Efficacy Study of Two Silicon-based Products to Treat Scars | Ache Laboratorios Farmaceuticos S.A. | Not applicable | Withdrawn | Scars | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02584010) |
| October 21, 2015 | NCT02582996 | Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Suspended | Migraine | 336 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02582996) |
| October 21, 2015 | NCT02582177 | Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Completed | Tinea | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02582177) |
| October 21, 2015 | NCT02581397 | Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Terminated | Cough | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02581397) |
| April 6, 2015 | NCT02409381 | Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis | Ache Laboratorios Farmaceuticos S.A. | Phase 4 | Completed | Osteoarthritis, Knee | 288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02409381) |
| December 13, 2013 | NCT02010918 | Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Completed | Knee Osteoarthritis | 922 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02010918) |
| November 15, 2012 | NCT01726920 | Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Migraine, Headache | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01726920) |
| October 8, 2012 | NCT01702675 | Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug | Ache Laboratorios Farmaceuticos S.A. | Phase 1 | Terminated | Healthy | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01702675) |
| September 28, 2012 | NCT01695616 | Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | Withdrawn | Climacteric Syndrome | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01695616) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 28 |
| Phase 4 | 3 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Withdrawn | 13 |
| Completed | 10 |
| Unknown | 5 |
| Suspended | 3 |
| Not yet recruiting | 3 |
| Terminated | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Common Cold | 6 |
| Migraine Disorders | 4 |
| Headache | 4 |
| Nasal Obstruction | 3 |
| Cough | 3 |
| Inflammation | 3 |
| Rhinitis | 3 |
| Epilepsy | 3 |
| Osteoarthritis, Knee | 2 |
| Low Back Pain | 2 |
| Asthma | 2 |
| Influenza, Human | 1 |
| Cicatrix | 1 |
| Diarrhea | 1 |
| Acute Pain | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Prostatic Hyperplasia | 1 |
| Vitiligo | 1 |
| Vaginal Discharge | 1 |
| Tinea | 1 |
| Mycoses | 1 |
| Cellulitis | 1 |
| Hypercholesterolemia | 1 |
| Dyslipidemias | 1 |
| Alopecia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Meat wholesalers in the United States](https://specstream.ai/data/businesses/meat-wholesalers/united-states)
- [Prosthetics providers in the United States](https://specstream.ai/data/businesses/prosthetics-providers/united-states)
- [Trailer repair shops in the United States](https://specstream.ai/data/businesses/trailer-repair-shops/united-states)
- [B2B mining companies in the United States](https://specstream.ai/data/businesses/b2b-mining-companies/united-states)
- [Cosmetic products manufacturers in the United States](https://specstream.ai/data/businesses/cosmetic-products-manufacturers/united-states)
